- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06480825
Application of Ultra-high Frequency Ultrasonography (UHFUS) to the Study of Gingival Tissues
Ulta-High Frequency Ultrasound Assessment of Normal Versus Gingivitis Affected Gingival Tissues
Gingival inflammation triggered by the accumulation of bacterial is the primary risk factor for the development of periodontitis. Clinically, localized signs of inflammation limited to the gingiva, presence of significant bacterial plaque load, and stable attachment levels on the periodontium can be observed in course of gingivitis. The aim of the present study is to compare clinical aspects of gingival tissue in healthy patients versus patients with gingivitis to assess the ultrastructural variations present in course of inflammation.
Patients with gingivitis and healthy controls will be enrolled. All patients will undergo ultra-high frequency ultrasonographic scans (70 MHz) of gingival tissue on three areas per dental arch (anterior, middle right, middle left). Gingival thickness, echogenicity, and vascularization assessed through resisitive index will be evaluated.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Rossana Izzetti
- Phone Number: 3475205619
- Email: rossana.izzetti@unipi.it
Study Locations
-
-
-
Pisa, Italy
- Recruiting
- Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University Hospital of Pisa
-
Contact:
- Rossana Izzetti
- Phone Number: 3475205619
- Email: rossana.izzetti@unipi.it
-
-
Italy
-
Pisa, Italy, Italy, 56126
- Recruiting
- University of Pisa
-
Contact:
- Rossana Izzetti
- Phone Number: +39050993037
- Email: rossana.izzetti@unipi.it
-
Principal Investigator:
- Rossana Izzetti
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- males or females of age > 18 years
- presence of at least 20 teeth
- full-mouth plaque score (FMPS) >50%
- FMBS >30%
- ability and willingness to give informed consent
Exclusion Criteria:
- pregnancy or breastfeeding
- pharmacological treatment with antinflammatory drugs, statins, or either local or systemic antibiotics (within the previous 30 days)
- smoking habit
- dental or periodontal condition requiring immediate treatment
- refusal to be enrolled in the study
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Gingivitis group
patients affected by gingivitis
|
Ultra-high frequency ultrasonographic scan of gingival tissues
|
|
Control group
Periodontally healthy patients
|
Ultra-high frequency ultrasonographic scan of gingival tissues
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Echogenicity
Time Frame: measured once at enrollemnt
|
Variations in echogenicity assessed through grey levels distribution between healthy patients versus gingivitis
|
measured once at enrollemnt
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Vascular parameters
Time Frame: measured once at enrollemnt
|
Variations in vascularization assessed through grey levels distribution between healthy patients versus gingivitis
|
measured once at enrollemnt
|
|
DMFT
Time Frame: measured once at enrollement
|
The Decayed-Missing-Filled Teeth (DMFT) index, categorized as Low (0-4), Moderate (5-13), and High (14+), will evaluate overall dental health.
|
measured once at enrollement
|
|
PPD
Time Frame: measured once at enrollement
|
Probing Pocket Depth (PPD) will be measured using a UNC-15 periodontal probe with 0.3 N pressure, recording six sites per tooth (distobuccal, buccal, mesiobuccal, distolingual, lingual, mesiolingual), rounded to the nearest millimeter.
|
measured once at enrollement
|
|
FMBS
Time Frame: measured once at enrollement
|
Full Mouth Bleeding Score (FMBS) will be determined dichotomously post-probing.
|
measured once at enrollement
|
|
FMPS
Time Frame: measured once at enrollement
|
Full Mouth Plaque Score (FMPS) will assess plaque presence on each tooth surface, with scores of 1 for presence and 0 for absence across six sites per tooth.
|
measured once at enrollement
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 7935870439
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.